Bisphosphonates cut elasticity of bones
Clopidogrel is cost-effective in combination with aspirin for treating patients with high-risk acute coronary syndromes, researchers conclude.
The US study, published in the Annals of Internal Medicine, found clopidogrel increased quality of life years to 9.61 from 9.51 with aspirin alone.
The cost of adding in clopidogrel was $15,400 per quality of life year gained, or £8,060, compared with a standard threshold for cost-effectiveness of £30,000.
The researchers, from Stanford University Medical Centre in California, compared patients receiving clopidogrel and aspirin for a year followed by aspirin monotherapy with those receiving aspirin alone.
It comes after a recent study in the New England Journal of Medicine question-ed the use of clopidogrel in patients with a history of aspirin-induced ulcer bleeding.